Criteria and Concurrent Validity of Adult ADHD Section of the Psychiatry Research Interview for Substance and Mental Disorders

Journal of Attention Disorders

Volumn 19, Issue 12, 2015, Pages 999-1006

  Ramos Quiroga, Josep Antoni ^a,b,c   Díaz Digon, Laura ^d,e   Comín, Marina ^a   Bosch, Rosa ^a,b,c   Palomar, Gloria ^a   Chalita, J Pablo ^a   Roncero, Carlos ^a,b,c   Nogueira, Mariana ^a,b,c   Torrens, Marta ^c,e   Casas, Miguel ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Institute of Neuropsychiatry and Addictions INAD   (Spain)

^e HOSPITAL DEL MAR   (Spain)

Author keywords

ADHD; adult ADHD; alcohol dependence; comorbidity; psychometrics

Indexed keywords

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE CONTROL STUDY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84946565631     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054712454191     Document Type: Article

References (53)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. M.Arcos-BurgosM.JainM.T.AcostaS.ShivelyH.StanescuD.WallisM..Muenke (2010). A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Molecular Psychiatry, 15, 1053-1066. doi:10.1038/mp.2010.6
3. M.AstalsL.DíazA.Domingo-SalvanyR.Martín-SantosA.BulbenaM.Torrens (2009). Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: An 18-month follow-up study. International Journal of Environmental Research and Public Health, 6, 2822-2832. doi:10.3390/ijerph6112822
4. M.AstalsA.Domingo-SalvanyC.C.BuenaventuraJ.TatoJ.M.VazquezR.Martín-SantosM.Torrens (2008). Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Substance Use and Misuse, 43, 612-632. doi:10.1080/10826080701204813
5. R.A.Barkley (2002). Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63(12), 10-15. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12562056
6. R.A.BarkleyM.Gordon (2002). Research on comorbidity, adaptative functioning, and cognitive impairments in adults with ADHD: Implication for a clinical practice. In S.GoldsteinA.T.Ellison (Eds.), Clinician’s guide to adult ADHD: Assessment and intervention (pp. 43-69). San Diego, CA: Academic Press.
7. J.BiedermanS.V.FaraoneE.MickT.SpencerT.WilensK.KielyR.Warburton (1995). High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: A pilot study. American Journal of Psychiatry, 152, 431-435. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7864271
8. J.BiedermanS.V.FaraoneT.SpencerT.WilensD.NormanK.A.LapeyA.Doyle (1993). Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 150, 1792-1798. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8238632
9. J.BiedermanC.R.PettyA.ClarkeA.LomedicoS.V.Faraone (2011). Predictors of persistent ADHD: An 11-year follow-up study. Journal of Psychiatric Research, 45, 150-155. doi:10.1016/j.jpsychires.2010.06.009
10. C.Daigre BlancoJ.A.Ramos-QuirogaS.ValeroR.BoschC.RonceroB.GonzalvoM.Nogueira (2009). Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom checklist in patients with substance use disorders. Actas Españolas de Psiquiatría, 37, 299-305. Retrieved from http://www.ncbi.lm.nih.gov/pubmed/20066581
11. K.DemyttenaereR.BruffaertsJ.Posada-VillaI.GasquetV.KovessJ.P.Lepine,.. WHO World Mental Health Survey Consortium. (2004). Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. Journal of the American Medical Association, 291, 2581-2590. doi:10.1001/jama.291.21.2581
12. G.DuPaulT.PowerA.AnastopoulosR.Reid (1998). ADHD Rating Scale–IV: Checklists, norms, and clinical interpretation. New York, NY: Guilford.
13. J.N.EpsteinS.H.Kollins (2006). Psychometric properties of an Adult ADHD Diagnostic Interview. Journal of Attention Disorders, 9, 504-514. doi:10.1177/1087054705283575
14. S.V.FaraoneJ.BiedermanE.Mick (2006). The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychological medicine, 36(2), 159-165. doi: 10.1017/S003329170500471X
15. J.FayyadR.De GraafR.KesslerJ.AlonsoM.AngermeyerK.DemyttenaereR..Jin (2007). Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. British Journal of Psychiatry, 190, 402-429. doi:10.1192/bjp.bp.106.034389
16. N.Fernàndez-CastilloM.RibasésC.RonceroM.CasasB.GonzalvoB.Cormand (2010). Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample. Psychiatric Genetics, 20, 317-320. doi:10.1097/YPG.0b013e32833b6320
17. B.FrankeA.A.VasquezS.JohanssonM.HoogmanJ.RomanosA.Boreatti-HümmerA..Reif (2010). Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology, 35, 656-664. doi:10.1038/npp.2009.170
18. T.Frodl (2010). Comorbidity of ADHD and substance use disorder (SUD): A neuroimaging perspective. Journal of Attention Disorders, 14, 109-120. doi:10.1177/1087054710365054
19. D.HasinS.SametE.NunesJ.MeydanK.MatseoaneR.Waxman (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders forDSM-IV. American Journal of Psychiatry, 163, 689-696. doi:10.1176/appi.ajp.163.4.689
20. K.A.HennesseyM.D.SteinC.RosengardJ.S.RoseJ.G.Clarke (2010). Childhood attention deficit hyperactivity disorder, substance use, and adult functioning among incarcerated women. Journal of Attention Disorders, 14, 273-280. doi:10.1177/1087054709347185
21. M.J.HerreroA.Domingo-SalvanyM.TorrensM.T.Brugal, & ITINERE Investigators. (2008). Psychiatric comorbidity in young cocaine users: Induced versus independent disorders. Addiction, 103, 284-293. doi:10.1111/j.1360-0443.2007.02076.x
22. T.M.KellyJ.R.CorneliusD.B.Clark (2004). Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug and Alcohol Dependence, 73, 87-97. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14687963
23. R.C.KesslerL.E.AdlerM.AmesR.A.BarkleyH.BirnbaumP.GreenbergT.B..Ustun (2005). The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. Journal of Occupational and Environmental Medicine, 47, 565-572. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15951716
24. R.C.KesslerP.BerglundO.DemlerR.JinK.R.MerikangasE.E.Walters (2005). Lifetime prevalence and age of onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593-602. doi:10.1001/archpsyc.62.6.593
25. R.C.KesslerW.T.ChiuO.DemlerK.R.MerikangasE.E.Walters (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617-627. doi:10.1001/archpsyc.62.6.617
26. J.H.KhalsaG.TreismanE.McCance-KatzE.Tedaldi (2008). Medical consequences of drug abuse and co-occurring infections: Research at the National Institute on Drug Abuse. Substance Abuse, 29(3), 5-16. doi:10.1080/08897070802218661
27. M.KolpeG.A.Carlson (2007). Influence of attention-deficit/hyperactivity disorder symptoms on methadone treatment outcome. American Journal on Addictions, 16, 46-48. doi:10.1080/10601330601080073
28. J.J.KooijJ.K.BuitelaarE.J.van den OordJ.W.FurerC.A.RijndersP.P.Hodiamont (2005). Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychological Medicine, 35, 817-827. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15997602
29. S.J.KooijS.BejerotA.BlackwellH.CaciM.Casas-BruguéP.J.CarpentierP..Asherson (2010). European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry, 10, 67. doi:10.1186/1471-244X-10-67
30. C.LaraJ.FayyadR.de GraafR.C.KesslerS.Aguilar-GaxiolaM.AngermeyerN..Sampson (2009). Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biological Psychiatry, 65(1), 46-54. doi: 10.1016/j.biopsych.2008.10.005
31. F.R.LevinS.M.EvansH.D.Kleber (1998). Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence, 52(1), 15-25. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9788002
32. S.MannuzzaR.G.KleinJ.L.MoultonIII. (2008). Lifetime criminality among boys with attention deficit hyperactivity disorder: A prospective follow-up study into adulthood using official arrest records. Psychiatry Research, 160, 237-246. doi:10.1016/j.psychres.2007.11.003
33. S.MannuzzaR.G.KleinN.L.TruongJ.L.MoultonIIIE.R.RoizenK.H.HowellF.X.Castellanos (2008). Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: Prospective follow-up into adulthood. American Journal of Psychiatry, 165, 604-609. doi:10.1176/appi.ajp.2008.07091465
34. R.MedoriJ.A.Ramos-QuirogaM.CasasJ.J.KooijA.NiemeläG.E.TrottJ.K.Buitelaar (2008). A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 63, 981-989. doi:10.1016/j.biopsych.2007.11.008
35. J.ModestinB.MatutatO.Wurmle (2001). Antecedents of opioid dependence and personality disorder: Attention-deficit/hyperactivity disorder and conduct disorder. European Archives of Psychiatry & Clinical Neuroscience, 251, 42-47. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11315518
36. M.D.OhlmeierK.PetersB.T.Te WildtM.ZedlerM.ZiegenbeinB.WieseU.Schneider (2008). Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD). Alcohol and Alcoholism, 43, 300-304. doi:10.1093/alcalc/agn014
37. J.A.Ramos-QuirogaR.BoschV.RicharteS.ValeroN.Gómez-BarrosM.NogueiraM..Casas (2012). Validez de criterio y concurrente de la versión española de la Conners Adult ADHD Diagnostic Interview for DSM-IV (CAADID). Revista de Psiquiatría y Salud Mental. Advance online publication. http://dx.doi.org/10.1016/j.rpsm.2012.05.004
38. J.A.Ramos-QuirogaR.Bosch-MunsóX.Castells-CervellóM.Nogueira-MoraisE.García-GimenezM.Casas-Brugué (2006). Attention deficit hyperactivity disorder in adults: A clinical and therapeutic characterization. Revista de Neurología, 42, 600-606. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16703528
39. M.RibasésJ.A.Ramos-QuirogaA.HervásR.BoschA.BielsaX.GastaminzaM..Bayés (2009). Exploration of 19 serotoninergic candidate genes in adults and children with attention deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Molecular Psychiatry, 14, 71-85. doi:10.1038/sj.mp.4002100
40. M.C.Rodríguez-LleraA.Domingo-SalvanyM.T.BrugalT.C.SilvaA.Sánchez-NiubóM.Torrens, & ITINERE Investigators. (2006). Psychiatric comorbidity in young heroin users. Drug and Alcohol Dependence, 84, 48-55. doi:10.1016/j.drugalcdep.2005.11.025
41. M.A.Serra-PinheiroE.S.CoutinhoI.S.SouzaC.PinnaD.FortesC.AraújoP.Mattos (2012). Is ADHD a risk factor independent of conduct disorder for illicit substance use? A meta-analysis and metaregression investigation. Journal of Attention Disorders. Advance online publication. doi:10.1177/1087054711435362
42. V.SimonP.CzoborS.BalintA.MeszarosI.Bitter (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder: Meta-analysis. British Journal of Psychiatry, 194, 204-211. doi:10.1192/bjp.bp.107.048827
43. M.A.SullivanF.Rudnik-Levin (2001). Attention deficit/hyperactivity disorder and substance abuse: Diagnostic and therapeutic considerations. Annals of the New York Academy of Sciences, 931, 251-270. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11462745
44. E.TaylorO.ChadwickE.HeptinstallM.Danckaerts (1996). Hyperactivity and conduct problems as risk factors for adolescent development. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 1213-1226. doi:10.1097/00004583-199609000-00019
45. M.ThavorncharoensapY.TeerawattananonJ.YothasamutC.LertpitakpongU.Chaikledkaew (2009). The economic impact of alcohol consumption: A systematic review. Substance Abuse Treatment, Prevention, and Policy, 25(4), 20. doi:10.1186/1747-597X-4-20
46. M.TorrensG.GilchristA.Domingo-Salvany, & psyCo-Barcelona Group. (2011). Psychiatric comorbidity in illicit drug users: Substance-induced versus independent disorders. Drug and Alcohol Dependence, 113, 147-156. doi:10.1016/j.drugalcdep.2010.07.013
47. M.TorrensD.SerranoM.AstalsG.Pérez-DomínguezR.Martín-Santos (2004). Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. American Journal of Psychiatry, 161, 1231-1237. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15229056
48. M.TuithofM.Ten HaveW.van den BrinkW.VolleberghR.de Graaf (2011). The role of conduct disorder in the association between ADHD and alcohol use (disorder). Results from the Netherlands Mental Health Survey and Incidence Study-2. Drug and Alcohol Dependence, 123, 115-121. doi:10.1016/j.drugalcdep.2011.10.030
49. N.D.VolkowG.J.WangS.H.KollinsT.L.WigalJ.H.NewcornF.TelangJ.M.Swanson (2009). Evaluating dopamine reward pathway in ADHD: Clinical implications. Journal of the American Medical Association, 302, 1084-1091. doi:10.1001/jama.2009.1308
50. M.F.WardP.H.WenderF.W.Reimherr (1993). The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry, 150, 885-890. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8494063
51. T.E.Wilens (2007). The nature of the relationship between attention deficit/hyperactivity disorder and substance use. Journal of Clinical Psychiatry, 68(Suppl. 11), 4-8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18307375
52. T.E.WilensM.MartelonG.JoshiC.BatemanR.FriedC.PettyJ.Biederman (2011). Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 50, 543-553. doi:10.1016/j.jaac.2011.01.021
53. S.YoungB.TooneC.Tyson (2003). Comorbidity and psychosocial profile in adults with attention deficit hyperactivity disorder. Personality and Individual Differences, 35, 743-755. doi:10.1016/S0191-8869(02)00267-2